A Narrative Review: Efficacy and Safety the Used of Corticosteroids as an Adjunct Therapy for Rheumatoid Arthritis

https://doi.org/10.55299/ijphe.v2i1.262

Authors

  • Hendra Herman Faculty of Pharmacy, Universitas Muslim Indonesia, Makassar, Indonesia, & Clinical Pharmacy, Ibnu Sina Hospital, Makassar, Indonesia
  • Irma Rachma Hanifah Faculty of Pharmacy, Universitas Muslim Indonesia, Makassar, Indonesia
  • Andi Maulana Kamri Faculty of Pharmacy, Universitas Muslim Indonesia, Makassar, Indonesia, & Clinical Pharmacy, Islamic Faisal Hospital, Makassar, Indonesia

Keywords:

Corticosteroids, Glucocorticoids, Rheumatoid, Rheumatoid Arthritis, Efficacy, Safety

Abstract

Rheumatoid Arthritis (RA) is an autoimmune disease characterized by inflammation of the joints. The selection of corticosteroids with broad indications is used as an adjunct therapy because of its anti-inflammatory activity and immune suppression. The research aimed to determine the efficacy and safety profile of corticosteroids in rheumatoid arthritis patients. The method used was a literature review with a narrative review design based on inclusion and exclusion criteria through the PubMed and Google Scholar databases. The results showed that the Prednisone group with varying doses of 5 mg; 6.25 mg; 10 mg gave better efficacy than the placebo group or Methotrexate monotherapy against disease activity with the DAS28 parameter. Prednisone safety was observed from the side effects, hypertension; hyperglycemia and adverse events, headache; reported diarrhea. The review show that the use of Prednisone tab 10 mg/day provided the best efficacy in the first 3 months (p<0.001) with the DAS28 parameter which achieved the greatest clinical remission. The side effects of Prednisone could not be concluded between the effect of dose and the level of drug safety.

Downloads

Download data is not yet available.

Published

2022-12-29

How to Cite

Hendra Herman, Irma Rachma Hanifah, & Kamri, A. M. (2022). A Narrative Review: Efficacy and Safety the Used of Corticosteroids as an Adjunct Therapy for Rheumatoid Arthritis. International Journal of Public Health Excellence (IJPHE), 2(1), 369–375. https://doi.org/10.55299/ijphe.v2i1.262